article thumbnail

Pharma CFO Anthony Doyle Plans for Uncertainty

CFO

“If we tell you something, it’s because we believe it, and we’re neither sandbaggers nor are we going to lead with our chin and put out outrageous goals,” said Anthony Doyle, CFO of BioCryst Pharmaceuticals, when asked to describe how the publicly held biotech has established credibility by executing on projections.

CFO 65
article thumbnail

Govt plans major capital goods production push

CFO News

India is considering expanding its capital goods promotion scheme to include sectors like pharmaceuticals and textiles. Plans are also being considered to introduce new-age technologies beyond electric vehicles, batteries, and automobile manufacturing.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

983: The CFO as Architect of Value | Aaron Alt, CFO, Cardinal Health

CFO Thought Leader

In the world of finance, where leadership roles await those who distinguish themselves along a select number of familiar paths, Aaron Alt’s journey to becoming a CFO stands out for its breadth and depth, transcending conventional boundaries. We’re a distributor of pharmaceutical products across the U.S.,

CFO 52
article thumbnail

CFO Pros on the Move: April

The Finance Weekly

Now, more than ever, the decisions made by the CFO are likely to affect the performance of the entire organization. In this article, we have compiled a list of some of the CFO moves that took place in April. CFO Pros on the Move April 2023 Jiajia Wu | Hyzon Motors , Jiajia Wu has been appointed as the interim CFO at Hyzon Motors.

CFO 52
article thumbnail

Hong Kong-based Immuno Cure BioTech names new CFO

Future CFO

Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park specialising in DNA vaccines and immunotherapies, announced recently the appointment of Mark Lo Chun Bun as CFO of the Group. More CFO appointment news The post Hong Kong-based Immuno Cure BioTech names new CFO appeared first on FutureCFO.

CFO 52
article thumbnail

Mubadala plans big deals in India's healthcare space

CFO News

Abu Dhabi's Mubadala Investment Company plans to expand in India's healthcare sector, seeking deals in the $200-500 million range. With a focus on pharmaceuticals, outsourced pharma services, and medtech, Mubadala aims to deploy capital meaningfully in India.

article thumbnail

ONGC plans to invest Rs 1 lakh cr to set up 2 petrochemical plants

CFO News

India's top oil and gas producer, ONGC, plans to invest approximately Rs 1 lakh crore in establishing two petrochemical plants to directly convert crude oil into high-value chemical products.